Results for 'Immunotherapies'
Median Survival or Mean Survival: Which Measure Is the Most Appropriate for Patients, Physicians, and Policymakers?
Jul 18th • 15 mins read
Value assessment of NMPA-approved new cancer drugs for solid cancer in China, 2016-2020
Feb 24th • 8 mins read
The FDA Oncology Center of Excellence and Precision Medicine
Nov 6th • 3 mins read